PURPOSE: To evaluate the role of CNS dopaminergic systems in Restless Legs
Syndrome (RLS), homovanillic acid (HVA), tetrahydrobiopterin (BH4), and neo
pterin (NEOP), were assayed in CSF from RLS patients. The serotonin metabol
ite, 5-hydroxyindoleacetic acid (5-HIAA), was also measured.
METHODS: CSF was taken from 16 RLS patients after 2 weeks off medication an
d from 14 control subjects. The CSF metabolites were determined using HPLC
techniques.
RESULTS: There was no significant difference in HVA or 5-HIAA, but NEOP and
BH4 were higher in RLS patients. The RLS group was significantly older tha
n the control group (64.2 +/- 9.2 years vs. 51.4 +/- 6.3 years; P < 0.001).
A multiple regression analysis showed a strong correlation between age and
5-HIAA (r = 0.46, P = 0.04) and between age and NEOP (r = 0.61, P < 0.01).
To eliminate the potential error created by the age difference between gro
ups, an age-adjusted subgroup of RLS and control subjects were compared. Th
ere was still no difference found for HVA; however, 5-HIAA was now signific
antly lower (P < 0.01) in the RLS subgroup. Age-adjustment eliminated the d
ifferences previously found for NEOP, (P = 0.12), but BH4 continued to rema
in higher in the RLS group (P < 0.01).
CONCLUSION: Differences in CSF HVA concentrations were not found. The chang
es in 5-HIAA and BH4 are of unclear clinical significance and require furth
er assessment with appropriate age-matched controls.